Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05165745 · ClinicalTrials.gov registry record · NA
Stick2PrEP Cisgender Women and Trans Individuals
A NA study of HIV Prevention and Pre-exposure Prophylaxis, sponsored by Columbia University.
- Recruiting
- Registry status
- NA
- Development phase
- 175
- Enrollment target
- 1
- Study location
NCT05165745: Recruiting NA study of HIV Prevention and Pre-exposure Prophylaxis, sponsored by Columbia University.
NCT05165745 is a NA study of HIV Prevention and Pre-exposure Prophylaxis that is actively recruiting participants, run by Columbia University. The registered enrollment target is 175 participants, below the 376-participant average among 32 other HIV Prevention trials with a reported enrollment target (53% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05165745, a NA study of HIV Prevention and Pre-exposure Prophylaxis, is actively recruiting participants, sponsored by Columbia University.
- RECRUITING
- Registry status
- NA
- Development phase
- 175 participants
- Enrollment target
- 1
- Study location
Study Summary
Taking a daily anti-HIV pill can protect people from HIV infection. This is called preexposure prophylaxis \[PrEP\]. Many cisgender women and trans individuals do not know this medication is available; others struggle to take the pill every day. It is important to understand attitudes and preferences about HIV prevention options, especially as new options become available. This study plans to evaluate preferences over time among cisgender women and trans individuals who are taking medication to prevent HIV, and among cisgender women and trans individuals who are not taking medication but are at risk of HIV. The investigators enroll up to 175 participants who visit the HIV prevention clinic, and the investigators will ask participants to complete questionnaires at regular follow up visits and between visits. This study may help the investigators understand how best to prevent HIV among people at risk.
Primary Outcome
Description of CWTI's preferences for different PrEP modalities and the relationship between preference and PrEP initiation/persistence in care. Preferences are evaluated using questionnaires developed by the study team; questions include ranked choice and Likert score responses. Persistence in care is measured by using the electronic medical record to track sexual health care visits over study period.
Conditions Studied
Interventions
- BEHAVIORAL Individualized Feedback
Study Locations (1)
New York
- Columbia University Medical Center - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 175 participants |
| Start Date | 2021-10-25 |
| Est. Completion | 2026-10-25 |
| Phase | NA |
What NCT05165745 shows while recruiting
NCT05165745 is an interventional study that assigns participants to a tested intervention. The registered 175 participants enrollment target is mid-sized for trials with a published cap, below the 376-participant average among 32 other HIV Prevention trials with a reported enrollment target (53% lower).
The record links to 2 conditions, with HIV Prevention appearing as the primary indexed condition, and to 1 intervention - of which Individualized Feedback is the first listed.
NCT05165745 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT05165745 about?
NCT05165745 is a clinical study titled "Stick2PrEP Cisgender Women and Trans Individuals". Taking a daily anti-HIV pill can protect people from HIV infection. This is called preexposure prophylaxis \[PrEP\]. Many cisgender women and trans individuals do not know this medication is available; others struggle to take the pill every day. It is important to understand attitudes and preference...
What is the current status of trial NCT05165745?
This trial is currently recruiting. It is a NA study. The enrollment target is 175 participants. The study started on 2021-10-25. Estimated completion is 2026-10-25.
What conditions does trial NCT05165745 study?
This clinical trial studies the following conditions: HIV Prevention, Pre-exposure Prophylaxis.
What interventions are being tested in trial NCT05165745?
The interventions under investigation include: Individualized Feedback (BEHAVIORAL).
Who is sponsoring clinical trial NCT05165745?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05165745 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HIV Prevention
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05165745's enrollment target sits among peer trials
175 14th of 32 higher than 19 of 32 other HIV Prevention trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other HIV Prevention trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Using PrEP, Doing It for Ourselves
RECRUITING · NA
-
Client-Centered Care Coordination for Black Men Who Have Sex With Men
RECRUITING · NA
-
Behavioral Economic Intervention to Improve HIV Behaviors in Sexual Minority Individuals
RECRUITING · NA
-
Intervention to Enhance PrEP Persistence
RECRUITING · NA
-
WePrEP: Developing a PrEP Shared Decision-making Tool for Transgender Women
RECRUITING · NA
-
Hybrid Evaluation of a Home-based HIV Pre-exposure Prophylaxis Program
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04722341 · 175 participants · NA
Time-Restricted Eating and Cancer: Clinical Outcomes, Mechanisms, and Moderators
- NCT05094037 · 175 participants · NA
Orthotic Treatment of Diabetic Foot Ulcers
- NCT05312255 · 175 participants · NA
Non-chemotherapeutic Interventions for the Improvement of Quality of Life and Immune Function in Patients With Multiple Myeloma
- NCT05335876 · 175 participants · Phase 3
Long-term Follow-up of Patients With Spinal Muscular Atrophy Treated With OAV101 in Clinical Trials
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI